Cboe CA - Delayed Quote CAD
AMGEN CDR (CAD HEDGED) (AMGN.NE)
21.18
-0.74
(-3.38%)
At close: May 2 at 1:58:09 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
12,192,000
11,490,000
8,471,000
9,721,000
9,261,000
Investing Cash Flow
-1,276,000
-1,046,000
-26,204,000
-6,044,000
733,000
Financing Cash Flow
-11,814,000
-9,415,000
21,048,000
-4,037,000
-8,271,000
End Cash Position
8,810,000
11,973,000
10,944,000
7,629,000
7,989,000
Capital Expenditure
-1,277,000
-1,096,000
-1,112,000
-936,000
-880,000
Issuance of Debt
--
--
27,777,000
6,919,000
4,945,000
Repayment of Debt
-6,100,000
-3,600,000
-1,454,000
--
-4,150,000
Repurchase of Capital Stock
--
-200,000
--
-6,360,000
-4,975,000
Free Cash Flow
10,915,000
10,394,000
7,359,000
8,785,000
8,381,000
12/31/2021 - 5/2/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GILD.NE Gilead Sciences, Inc.
21.61
+0.28%
ROG.NE Roche Holding AG
21.31
+0.47%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
7.41
+3.64%
ABBV.NE AbbVie Inc.
28.41
+2.38%
LLY.NE Eli Lilly and Company
30.45
+3.85%
GLAXF GSK plc
18.95
0.00%
PFE.NE Pfizer Inc.
11.12
+0.91%
NVS Novartis AG
114.29
+2.66%
GILD Gilead Sciences, Inc.
103.68
+0.42%
JNJ Johnson & Johnson
156.12
+1.07%